Fluocinolone acetonide for the treatment of diabetic macular edema
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1363182
Abstract: ABSTRACT Introduction: Fluocinolone acetonide intravitreal implant is a non-erodible implant approved for the treatment of diabetic macular edema (DME) insufficiently responsive to available therapies. Areas covered: The injectable intravitreal implant releases fluocinolone acetonide at an… read more here.
Keywords: treatment diabetic; intravitreal implant; diabetic macular; fluocinolone acetonide ... See more keywords
Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Ophthalmology"
DOI: 10.1177/1120672120901691
Abstract: Objective: To evaluate, in the setting of persistent diabetic macular edema, the impact that continuous fluocinolone acetonide delivery has on treatment burden, visual acuity, central retinal thickness, and intraocular pressure. Materials and methods: A single-center,… read more here.
Keywords: diabetic macular; fluocinolone acetonide; fluocinolone; persistent diabetic ... See more keywords
Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine–Gass Syndrome
Sign Up to like & getrecommendations! Published in 2021 at "International Medical Case Reports Journal"
DOI: 10.2147/imcrj.s295045
Abstract: Background Cystoid macular edema (CME) due to Irvine–Gass syndrome (IGS) is one of the common causes of painless visual impairment post-cataract extraction. The treatment of recurrent cases remains unstandardized. Objective To evaluate the effectiveness and… read more here.
Keywords: fluocinolone acetonide; cystoid macular; irvine gass; fluocinolone ... See more keywords